Dynamic Contrast Enhanced MRI(DCE-MRI)of Bone Tumors

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
SarcomaBone Tumor
Interventions
OTHER

DCE-MRI

"Patients will undergo DCE-MRI prior to, and within 18-24 days of starting chemotherapy. These studies are designed to determine if the DCE-MRI data will provide an a priori or early prognostic marker of tumor response. The dynamic MRI is done on a standard clinical scanner using standard techniques described below.~MR imaging studies will be acquired on a 1.5T GE (Milwaukee,WI) Signa LX scanner."

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
collaborator

New York Presbyterian Hospital

OTHER

collaborator

University of Oregon

OTHER

collaborator

University College, London

OTHER

collaborator

Montefiore Medical Center

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00598741 - Dynamic Contrast Enhanced MRI(DCE-MRI)of Bone Tumors | Biotech Hunter | Biotech Hunter